Managing the Risk of Delayed Breast Cancer Screening Versus COVID-19 Vaccination Associated Axillary Lymphadenopathy
- PMID: 34400078
- PMCID: PMC8349681
- DOI: 10.1016/j.acra.2021.07.022
Managing the Risk of Delayed Breast Cancer Screening Versus COVID-19 Vaccination Associated Axillary Lymphadenopathy
Comment on
-
COVID-19 Vaccination Induced Lymphadenopathy in a Specialized Breast Imaging Clinic in Israel: Analysis of 163 cases.Acad Radiol. 2021 Sep;28(9):1191-1197. doi: 10.1016/j.acra.2021.06.003. Epub 2021 Jun 10. Acad Radiol. 2021. PMID: 34257025 Free PMC article.
References
-
- Society of Breast Imaging, SBI Recommendations for the Management of Axillary Adenopathy in Patients with Recent COVID-19 Vaccination. SBI-online.org website updated 3/9/2021. Accessed on 7/14/2021.
-
- Centers for Disease Control and Prevention, Local Reactions, Systemic Reactions, Adverse Events, and Serious Adverse Events: Moderna COVID-19 Vaccine.
-
- Hendrick Breast Cancer Deaths Averted Over 3 Decades. Cancer. 2019;125:1482–1488. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical